About the Authors
- Valeria Capurro
-
Affiliation Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy
- Perrine Busquet
-
Affiliation Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy
- Joao Pedro Lopes
-
Affiliation Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy
- Rosalia Bertorelli
-
Affiliation Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy
- Glauco Tarozzo
-
Affiliation Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy
- Maria Laura Bolognesi
-
Affiliation Department of Pharmacy and Biotechnology, Bologna University, Bologna, Italy
- Daniele Piomelli
-
Affiliations Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy, Departments of Anatomy and Neurobiology, Pharmacology and Biological Chemistry, University of California Irvine, Irvine, United States of America
- Angelo Reggiani
-
Affiliation Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy
- Andrea Cavalli
-
* E-mail: andrea.cavalli@iit.it
Affiliations Drug Discovery and Development, Istituto Italiano di Tecnologia, Genoa, Italy, Department of Pharmacy and Biotechnology, Bologna University, Bologna, Italy
Competing Interests
AC and MLB have a patent application for Memoquin (WO03087035 A1 20031023). AC is Editorial Board member. These conflicts of interest do not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceived and designed the experiments: VC PB JPL RB GT AR AC. Performed the experiments: VC PB JPL. Analyzed the data: VC PB JPL RB GT. Wrote the paper: VC PB JPL RB GT MLB DP AR AC.